Elequin Capital’s Cartesian Growth Corp II RENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,200
Closed -$23.9K 468
2023
Q3
$23.9K Hold
2,200
﹤0.01% 213
2023
Q2
$23.5K Hold
2,200
0.01% 218
2023
Q1
$23.1K Hold
2,200
0.02% 152
2022
Q4
$22.6K Hold
2,200
0.01% 386
2022
Q3
$22K Buy
+2,200
New +$22.1K 0.01% 151

Other funds holding RENE

Elequin Capital's RENE Position: Q4 2023 in Review

Elequin Capital sold out of Cartesian Growth Corp II (RENE) in Q4 2023, closing a stake of 2,200 shares — an estimated $23.9K sold.

Elequin Capital first reported a position in RENE in Q3 2022 and held it in 5 quarters. The position peaked at $23.9K in Q3 2023. 34 funds tracked by Wall St. Rank hold RENE as of Q4 2023.

  • Elequin Capital reported no remaining Cartesian Growth Corp II position as of Q4 2023 after selling out during the quarter.
  • Elequin Capital sold 2,200 Cartesian Growth Corp II shares in Q4 2023, an estimated $23.9K.
  • Elequin Capital first reported a position in Cartesian Growth Corp II in Q3 2022 and held it in 5 quarters.
  • Elequin Capital's Cartesian Growth Corp II position peaked at $23.9K in Q3 2023.
  • 34 funds tracked by Wall St. Rank held Cartesian Growth Corp II as of Q4 2023.

Based on Elequin Capital's 13F filing for Q4 2023, filed 14 Feb 2024.